Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Clear all

1,174 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200015
200120
200220
200317
200427
200529
200639
200744
200860
200978
201046
201151
201254
201353
201462
201559
201660
201760
201866
201963
202051
202168
202248
202324
202419
20257

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,174

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)47
Sun Yat-sen University38
Bayer30
Eastern Hepatobiliary Surgery Hospital30
Seoul National University Hospital26
Chinese University of Hong Kong12
Kaohsiung Medical University Chung-Ho Memorial Hospital12
National Taiwan University Hospital12
Assistance Publique - Hôpitaux de Paris11
Bristol-Myers Squibb11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular1,174
Liver Neoplasms250
Neoplasms75
Stomach Neoplasms75
Carcinoma, Non-Small-Cell Lung59
Carcinoma, Renal Cell59
Pancreatic Neoplasms59
Esophageal Neoplasms47
Colonic Neoplasms45
Bile Duct Neoplasms44

Trials

Showing 76 to 100 of 1,174. Each trial links to its page on Pharma Observatory.

1,074 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.